Biproxi
Biproxi operates an invitation-only, subscription-based commercial real estate capital network platform that connects vetted CRE sponsors seeking capital with institutional investors and family offices seeking deal flow across the US, Canada, UK, and select European countries.
- Company typePrivate
- Founded2015
- HeadquartersBozeman, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Biproxi does
Biproxi (Biproxi, Inc.) is a private, Delaware-incorporated commercial real estate technology company operating an invitation-only capital network platform that connects CRE sponsors seeking capital with institutional investors, family offices, and capital providers seeking deal flow. The core product, the Biproxi Capital Network (hosted at capitalnetwork.biproxi.com), is a web-based membership platform where vetted members create profiles, specify investment criteria, browse investor information, post investment opportunities (Deals), and exchange direct invitations to view those deals. The company also operates a mobile application and a wholly-owned subsidiary, Biproxi Capital Advisors, a boutique capital advisory arm providing deal structuring, equity placement, debt advisory, and structured finance services for larger and more complex transactions.
The company monetizes primarily through subscription-based membership access to the network, with monthly, semi-annual, and annual billing cycles and automatic renewal. Investors joining as capital partners are onboarded without fees, while sponsors pay for advanced search, deal posting, and member invitation capabilities. The advisory subsidiary generates transaction-based revenue in addition to platform subscriptions, and the company claims $25B+ in aggregate transaction volume across US, Canada, UK, Europe, and Asia through that arm.
Biproxi is led by co-founders Gordon Smith (CEO; former CRE division head at Ten-X, with prior roles at Fortress Investment Group and BlackRock executing $10B+ in transactions) and Ember Erickson (COO; former COO of OfficeSpace.com, which Biproxi acquired in 2020). The team of 11-50 employees is headquartered in Bozeman, Montana with a regional office in Toronto, Canada, and the platform claims 700+ investors, 600+ capital partners, $2T+ in accessible dry powder, and coverage of 800+ strategies spanning the full capital stack across multifamily, office, retail, industrial, mixed use, and emerging CRE asset classes in the US, Canada, UK, and select European countries.
Biproxi firmographics
Firmographics- Name
- Biproxi
- Legal name
- Biproxi, Inc.
- Website
- https://biproxi.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biproxi operates an invitation-only, subscription-based commercial real estate capital network platform that connects vetted CRE sponsors seeking capital with institutional investors and family offices seeking deal flow across the US, Canada, UK, and select European countries.
- Ownership category
- akta.pro rank
Biproxi industry classification
Industry- Product category
- Commercial Real Estate Capital Markets Platform
- NAICS
- Mortgage and Nonmortgage Loan Brokers (52231), Activities Related to Credit Intermediation (5223)
- SIC
- Loan Brokers (6163), Investment Advice (6282)
- akta.pro primary industry
- Commercial Real Estate Asset Management (BPAJAMAB)
- akta.pro secondary industry
- CRE Loan Syndication & Participation (FSALADAK)
Keywords
Where Biproxi is headquartered
LocationHeadquarters
- HQ city
- Bozeman
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Biproxi business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Membership Subscription: Access to the Biproxi Capital Network requires paid subscription. Subscription services include advanced search capabilities, posting Deals, and inviting other Members to view those Deals. Subscriptions are available on monthly, semi-annual, or annual billing cycles with automatic renewal.
- Fee-Free Connectivity for Investors: For capital partners/investors joining the network, there are no fees associated with joining as a capital partner.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Subscription-based membership with advanced platform features |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Biproxi product offering
Product offeringCore offering
Biproxi operates an invitation-only, cloud-based commercial real estate capital network that connects CRE sponsors (developers, operators) seeking capital with institutional investors, family offices, and capital providers. Members apply and are vetted before being admitted; once approved, they can create profiles, specify investment criteria, browse the investor directory, post investment opportunities (Deals), and invite other vetted members to view those Deals. The company also operates Biproxi Capital Advisors, a boutique capital advisory arm providing deal structuring, equity placement, debt advisory, and structured finance for larger and more complex transactions.
Product overview
Biproxi offers a unified platform consisting of the Biproxi Capital Network (the core membership-based software platform) and Biproxi Capital Advisors (the boutique capital advisory arm). The platform is invitation-only and connects commercial real estate investors, sponsors, and developers for capital raising and deal-making. The Biproxi Capital Network enables members to create professional profiles, search for investors, post and browse deals, and connect with capital partners. Biproxi Capital Advisors provides specialized capital advisory services including deal structuring, equity placement, and debt advisory for larger, more complex transactions.
Differentiator
Problem solved
Functional benefit
Products and services
- Biproxi Capital Network A membership-based software platform and professional network for commercial real estate investors, sponsors, and developers. Enables vetted members to create profiles, specify investment criteria, browse the investor directory, post Deals (investment opportunities), and invite other vetted members to view those Deals. Subscription-based with monthly, semi-annual, or annual billing and automatic renewal.
- Biproxi Capital Advisors Boutique capital advisory arm specializing in large and complex capital formation, offering deal structuring, equity placement, debt advisory, and structured finance services for commercial real estate transactions. The advisory team's aggregate investment volume across US, Europe, UK, Canada, and Asia exceeds $25 billion.
Quantifiable outcome
- 75% faster capital raise
- +3 more outcomes
Companies that use Biproxi
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Biproxi technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Biproxi partnerships and signals
Strategic signalScale indicators8 records
Recent moves6 records
Expansion highlights4 records
Biproxi competitors and assessment
Company assessmentDirect peers
- RealtyMogul: Online CRE investment platform connecting sponsors with individual and institutional capital across equity and debt offerings; comparable marketplace model.
- Ten-X (now part of CoStar): Online commercial real estate marketplace connecting buyers, sellers and capital providers; the closest direct competitor and the company Biproxi's CEO previously led, now operating within CoStar.
- Cadre: Technology-driven CRE investment platform providing institutional-quality deal access to individual and institutional investors; competing approach to curated sponsor-investor matching.
- Real Capital Markets (RCM): CRE capital-markets transaction marketplace for sale and financing of institutional-grade assets; overlaps with Biproxi on capital-raise matchmaking.
- CrowdStreet: Online CRE investment marketplace connecting sponsors with individual and institutional investors; directly competes with Biproxi on sponsor-to-capital matching.
- EquityMultiple: CRE investment platform offering curated debt and equity opportunities to accredited and institutional investors; overlaps with Biproxi on curated deal flow.
Emerging players
- Compstak: CRE lease and sale comp data platform used by brokers and investors; an emerging data-and-analytics player adjacent to Biproxi's network-driven capital-raise workflow.
- Cherre: CRE data and analytics platform aggregating property, market and capital-markets data for institutional owners; an emerging player targeting the same institutional CRE customer base.
- Northspyre: Cloud-based CRE project management and analytics platform serving owners, developers and capital providers; emerging proptech player addressing CRE capital-deployment workflows adjacent to Biproxi.
Broad incumbents
- CoStar Group: Dominant CRE data, analytics and marketplace provider that acquired Ten-X; overlaps with Biproxi in capital-markets matchmaking and operates LoopNet for listing distribution.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Biproxi social profiles
Digital presenceBiproxi financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biproxi leadership team
Management profileNumber of profiles
Profiles6 records
Biproxi subsidiaries and ownership
Company hierarchySubsidiaries1 record
Biproxi funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biproxi M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biproxi
What does Biproxi do?
Biproxi operates an invitation-only, cloud-based commercial real estate capital network that connects CRE sponsors (developers, operators) seeking capital with institutional investors, family offices, and capital providers. Members apply and are vetted before being admitted; once approved, they can create profiles, specify investment criteria, browse the investor directory, post investment opportunities (Deals), and invite other vetted members to view those Deals. The company also operates Biproxi Capital Advisors, a boutique capital advisory arm providing deal structuring, equity placement, debt advisory, and structured finance for larger and more complex transactions.
Is Biproxi a public or private company?
Biproxi is a private company. It is classified as venture growth investor backed and is currently operating.
When was Biproxi founded?
Biproxi was founded in 2015. It employs 11 to 50 people.
Where is Biproxi based?
Biproxi is headquartered in Bozeman, United States, in the North America region.
How does Biproxi make money?
Two revenue lines are on record. Membership Subscription is the primary driver. The others are fee-Free Connectivity for Investors.
Who are Biproxi's main competitors?
Direct peers on record are RealtyMogul, Ten-X (now part of CoStar), Cadre, Real Capital Markets (RCM), CrowdStreet and EquityMultiple. Emerging players are Compstak, Cherre and Northspyre. CoStar Group is listed as a broad incumbent.
Does Biproxi have an API?
No public API is recorded for Biproxi.
What industry is Biproxi in?
Biproxi's product category is Commercial Real Estate Capital Markets Platform. Its primary akta.pro industry code is BPAJAMAB, Commercial Real Estate Asset Management, with a secondary code of FSALADAK, CRE Loan Syndication & Participation. Its NAICS code is 52231 and its SIC code is 6163.